Clinical review reveals severe pulmonary and cerebral lesions in hereditary hemorrhagic telangiectasia, highlighting the risks of mismanagement and the value of genetic diagnosis.
Identified nearly a century ago, hereditary hemorrhagic telangiectasia, or Rendu–Osler–Weber syndrome, has long been viewed as a rare condition producing minor discomfort for affected persons. However, this disorder is now considered to be more common than previously thought,15 and the associated brain and pulmonary lesions are sources of substantial morbidity and mortality.3,68 Wider recognition of the condition and awareness of its sequelae can help avoid the considerable risks associated with its mismanagement. Advances in molecular genetics have demonstrated that hereditary hemorrhagic telangiectasia is actually a group of autosomal dominant disorders.913 The recent identification of the gene . . .
No takes yet. Share an insight, caveat, or question.
Guttmacher et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: